Your browser doesn't support javascript.
loading
Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2.
Francis, Joshua M; Leistritz-Edwards, Del; Dunn, Augustine; Tarr, Christina; Lehman, Jesse; Dempsey, Conor; Hamel, Andrew; Rayon, Violeta; Liu, Gang; Wang, Yuntong; Wille, Marcos; Durkin, Melissa; Hadley, Kane; Sheena, Aswathy; Roscoe, Benjamin; Ng, Mark; Rockwell, Graham; Manto, Margaret; Gienger, Elizabeth; Nickerson, Joshua; Moarefi, Amir; Noble, Michael; Malia, Thomas; Bardwell, Philip D; Gordon, William; Swain, Joanna; Skoberne, Mojca; Sauer, Karsten; Harris, Tim; Goldrath, Ananda W; Shalek, Alex K; Coyle, Anthony J; Benoist, Christophe; Pregibon, Daniel C.
Afiliación
  • Francis JM; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Leistritz-Edwards D; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Dunn A; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Tarr C; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Lehman J; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Dempsey C; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Hamel A; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Rayon V; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Liu G; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Wang Y; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Wille M; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Durkin M; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Hadley K; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Sheena A; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Roscoe B; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Ng M; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Rockwell G; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Manto M; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Gienger E; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Nickerson J; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Moarefi A; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Noble M; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Malia T; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Bardwell PD; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Gordon W; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Swain J; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Skoberne M; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Sauer K; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Harris T; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Goldrath AW; Division of Biological Sciences, Molecular Biology Section, University of California, San Diego, San Diego, CA, USA.
  • Shalek AK; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Coyle AJ; Department of Chemistry and Koch Institute for Integrative Cancer Research, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Benoist C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Pregibon DC; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Sci Immunol ; 7(67): eabk3070, 2022 01 21.
Article en En | MEDLINE | ID: mdl-34793243
ABSTRACT
Effective presentation of antigens by human leukocyte antigen (HLA) class I molecules to CD8+ T cells is required for viral elimination and generation of long-term immunological memory. In this study, we applied a single-cell, multiomic technology to generate a unified ex vivo characterization of the CD8+ T cell response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across four major HLA class I alleles. We found that HLA genotype conditions key features of epitope specificity, TCRα/ß sequence diversity, and the utilization of pre-existing SARS-CoV-2-reactive memory T cell pools. Single-cell transcriptomics revealed functionally diverse T cell phenotypes of SARS-CoV-2-reactive T cells, associated with both disease stage and epitope specificity. Our results show that HLA variations notably influence the CD8+ T cell repertoire shape and utilization of immune recall upon SARS-CoV-2 infection.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_pneumonia Asunto principal: Antígenos de Histocompatibilidad Clase I / Receptores de Antígenos de Linfocitos T alfa-beta / Linfocitos T CD8-positivos / Alelos / SARS-CoV-2 / COVID-19 / Células T de Memoria Límite: Humans Idioma: En Revista: Sci Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_pneumonia Asunto principal: Antígenos de Histocompatibilidad Clase I / Receptores de Antígenos de Linfocitos T alfa-beta / Linfocitos T CD8-positivos / Alelos / SARS-CoV-2 / COVID-19 / Células T de Memoria Límite: Humans Idioma: En Revista: Sci Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
...